The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+23.3% to $46.00
Predicted High$46.00at 6 months
Predicted Low$37.60in 2 weeks
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 5, 2026 1:03 pm
Bull
G trends higher to
$46.00
(+23.3% from $37.32)
by Mar 2027.
flat-then-break
ThesisDeeply undervalued Genpact with strong quality and consistent EPS beats should re-rate higher over six months as agentic-AI narrative gains traction, though near-term sentiment is muted and no catalyst is imminent. Path drifts sideways early then grinds upward toward the mid-40s as value gravity asserts.
Invalidated ifBreak below $34 on heavy volume or a BPO-automation guide-down would falsify the recovery thesis
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $37.32 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 5, 2026
—
$37.32at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 19, 2026
$34.39–$40.25typical range · internal point $37.60
—
±7.9%
7/10
Low-beta drift in risk-on regime, no catalyst
What actually happened:
closed $34.14
on Sep 18, 2026 = -8.5% vs the call
(predicted +0.8%)
· direction MISS
(called flat, was down)
· off by 9.3 pp
· accuracy 4/10
· typical range ±7.9%:
OUTSIDE the band
· S&P -0.9%
over the same window — lagged it
1 month
Oct 5, 2026
$33.07–$41.57typical range · internal point $38.20
—
±11.4%
6/10
Mild grind as value buyers nibble near support
What actually happened:
closed $33.29
on Oct 2, 2026 = -10.8% vs the call
(predicted +2.4%)
· direction MISS
(called flat, was down)
· off by 13.2 pp
· accuracy 4/10
· typical range ±11.4%:
inside the band
· S&P +0.1%
over the same window — lagged it
2 months
Nov 5, 2026
$39.80
—
+6.7%
5/10
Q3 print approaches, sixth beat anticipated
3 months
Dec 5, 2026
$42.00
—
+12.6%
6/10
Earnings beat and AI repositioning catalyze re-rating
4 months
Jan 5, 2027
$43.50
—
+16.6%
5/10
Post-earnings continuation as estimates lift
5 months
Feb 5, 2027
$44.80
—
+20.1%
4/10
Value gravity toward $61 fair value pulls higher
6 months
Mar 5, 2027
$46.00
—
+23.3%
4/10
Sustained re-rating but still well below fair value
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$51.10
(+36.9%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.